It won't have the same degree of weight loss from what we can see in the early trials, she advises, but it will help retain lean muscle mass, which we inevitably lose over our lifetime. Given that semaglutide is a lifelong drug, the long-term data on GLP-1 agonists is reassuringly positive
WeightWatchers Clinic (Vs
On-Label vs Off-Label and Compounded Products Vitamin B12 injections are an established medical treatment for confirmed B12 deficiency and related conditions (for example, pernicious anemia and certain malabsorption states), as summarized by the NIH Office of Dietary Supplements in its Vitamin B12 fact sheet for health professionals
In Phase 2 trials, participants achieved an average weight loss of 24.2% of their body weight over 48 weeks
As of 2022, GLP-1RAs have been recommended as first-line treatments, along with SGLT-2 inhibitors, for patients with T2DM and cardiovascular disease in American Diabetes Associations Standards of Medical Care in Diabetes (248, 249)